Bringing the fundamentals into focus…
Back to AbCellera Biologics Inc.
How AbCellera Biologics Inc. stacks up
ABCL · against 1,327 other Healthcare companies
Overall
47/ 100
Below the middle of the pack.
Ranked #738 of 1,328 · scores higher than 43% of peers
Bars: peers in each 10-point band of the overall score233 peers with an overall score of 40–49, including ABCL · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around ABCL| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 2 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 4 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 716 | 3.4B USD | 48 | 8 | 96 | 28 | 1 / 2 | |
| 716 | 1.3B USD | 48 | 60 | 51 | 59 | 2 / 2 | |
| 738 | 2.9B HKD (≈$366M) | 47 | 43 | 50 | 35 | 1 / 2 | |
| 738 | 2.8B CNY (≈$399M) | 47 | 54 | 11 | 48 | 0 / 2 | |
| 738 | 3.9B USD | 47 | 8 | 84 | 10 | 0 / 2 | |
| 738 | 3.1B EUR (≈$3.4B) | 47 | 64 | 39 | 58 | 2 / 2 | |
| 738 | 593.2B INR (≈$7.1B) | 47 | 41 | 38 | 63 | / 2 | |
| 738 | 54.0B USD | 47 | 57 | 45 | 53 | 2 / 2 | |
| 738 | 558.5B INR (≈$6.7B) | 47 | 50 | 39 | — | 1 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score